Today the United States Patent Office (USPTO) granted CRS Incorporated’s petition to have United States Patent Number 6,675,151, issued to Frontline Placement Technology, reexamined. The decision to grant the patent reexamination was due in part to the USPTO determining that there were a number of substantial new questions of patentability affecting claims 3-13 of the ‘151’ Patent. The basis for today’s decision relates to anticipation, obviousness, and Frontline’s failure to disclose all prior art.
“This is a very favorable ruling for CRS,” stated Steve Uzupis, Vice President, “and it affirms our position that the original ruling granting the patent to Frontline Placement did not take into consideration questions of obviousness and anticipation relating to prior art and the SubFinder system.